DK1684775T3 - Anvendelse af ekstrakter af pelargonium-species - Google Patents

Anvendelse af ekstrakter af pelargonium-species

Info

Publication number
DK1684775T3
DK1684775T3 DK04790852T DK04790852T DK1684775T3 DK 1684775 T3 DK1684775 T3 DK 1684775T3 DK 04790852 T DK04790852 T DK 04790852T DK 04790852 T DK04790852 T DK 04790852T DK 1684775 T3 DK1684775 T3 DK 1684775T3
Authority
DK
Denmark
Prior art keywords
lps
seconds
treatment
gen
mice
Prior art date
Application number
DK04790852T
Other languages
Danish (da)
English (en)
Inventor
Shyam Sunder Chatterjee
Egon Koch
Michael Noeldner
Original Assignee
Schwabe Willmar Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34258760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1684775(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schwabe Willmar Gmbh & Co filed Critical Schwabe Willmar Gmbh & Co
Application granted granted Critical
Publication of DK1684775T3 publication Critical patent/DK1684775T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK04790852T 2003-10-29 2004-10-26 Anvendelse af ekstrakter af pelargonium-species DK1684775T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10350338A DE10350338B3 (de) 2003-10-29 2003-10-29 Verwendung von Extrakten aus Pelargonium Spezies
PCT/EP2004/012069 WO2005041993A1 (de) 2003-10-29 2004-10-26 Verwendung von extrakten aus pelargonium-spezies

Publications (1)

Publication Number Publication Date
DK1684775T3 true DK1684775T3 (da) 2008-06-16

Family

ID=34258760

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04790852T DK1684775T3 (da) 2003-10-29 2004-10-26 Anvendelse af ekstrakter af pelargonium-species

Country Status (18)

Country Link
US (1) US7611734B2 (es)
EP (1) EP1684775B1 (es)
JP (1) JP2007509876A (es)
KR (1) KR20060127839A (es)
CN (1) CN1852723A (es)
AT (1) ATE390143T1 (es)
AU (1) AU2004285273B2 (es)
BR (1) BRPI0415868A (es)
CA (1) CA2540891A1 (es)
DE (2) DE10350338B3 (es)
DK (1) DK1684775T3 (es)
ES (1) ES2299877T3 (es)
MX (1) MXPA06003744A (es)
PL (1) PL1684775T3 (es)
PT (1) PT1684775E (es)
RU (1) RU2342941C2 (es)
UA (1) UA82381C2 (es)
WO (1) WO2005041993A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004032439A1 (de) * 2004-07-05 2006-02-02 Iso Arzneimittel Gmbh & Co Kg Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und Pelargonium reniforme
EP2134369B1 (de) * 2007-04-17 2019-01-02 Dr. Willmar Schwabe GmbH & Co. KG Verfahren zur herstellung von trockenextrakten aus pelargonium sidoides und pelargonium reniforme
KR100896453B1 (ko) * 2007-07-18 2009-05-14 닥터 빌마르 쉬바베 게엠바하 운트 코 카게 페라고늄 시도이데스 시럽
US9913869B2 (en) * 2012-10-17 2018-03-13 Montero Gida Sanayi Ve Ticaret A.S. Formulations comprising herbal extracts
EA201590564A1 (ru) * 2012-10-18 2015-09-30 Монтеро Гида Санайи Ве Тиджарет А.С. Стабильные составы
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
KR102207603B1 (ko) * 2019-07-02 2021-01-26 동의대학교 산학협력단 로즈제라늄 정유를 포함하는 수면 유도용 조성물
KR102244814B1 (ko) * 2019-07-17 2021-04-26 동의대학교 산학협력단 로즈제라늄 정유를 포함하는 스트레스 완화용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429735C2 (de) * 1994-08-22 1996-10-02 Mepat Ltd Pflanzlicher Redoxkatalysator, Mittel zur Behandlung immunbiologischer Zellbelastungsschwächen und Verfahren zu dessen Herstellung
GB2355189B (en) * 1999-08-20 2004-07-28 Yousef Haik Babikian Herbal preparation for the treatment of diabetes mellitus
US7128924B2 (en) * 2001-02-12 2006-10-31 Council Of Scientific & Industrial Research Safe, eco-friendly, health protective herbal colors and aroma useful for cosmaceutical applications
EP1429795B1 (de) * 2001-09-27 2007-06-13 Dr. Willmar Schwabe GmbH & Co. KG Verfahren zur herstellung von extrakten aus pelargonium sidoides und/oder pelargonium reniforme
GB2381195A (en) * 2002-07-12 2003-04-30 Clare G Harvey Orchid essence containing medicaments for the treatment of stress

Also Published As

Publication number Publication date
UA82381C2 (uk) 2008-04-10
EP1684775A1 (de) 2006-08-02
DE10350338B3 (de) 2005-04-07
WO2005041993A1 (de) 2005-05-12
BRPI0415868A (pt) 2007-01-09
RU2006108398A (ru) 2007-09-27
ATE390143T1 (de) 2008-04-15
JP2007509876A (ja) 2007-04-19
PT1684775E (pt) 2008-04-23
AU2004285273B2 (en) 2009-11-12
CA2540891A1 (en) 2005-05-12
PL1684775T3 (pl) 2008-09-30
ES2299877T3 (es) 2008-06-01
MXPA06003744A (es) 2006-06-14
AU2004285273A1 (en) 2005-05-12
KR20060127839A (ko) 2006-12-13
DE502004006688D1 (de) 2008-05-08
RU2342941C2 (ru) 2009-01-10
US20070014877A1 (en) 2007-01-18
EP1684775B1 (de) 2008-03-26
CN1852723A (zh) 2006-10-25
US7611734B2 (en) 2009-11-03

Similar Documents

Publication Publication Date Title
DK1684775T3 (da) Anvendelse af ekstrakter af pelargonium-species
Ezeamuzie et al. Antiinflammatory effects of Moringa oleifera root extract
Biney et al. Xylopia aethiopica fruit extract exhibits antidepressant-like effect via interaction with serotonergic neurotransmission in mice
AR025110A1 (es) Metodos y composiciones para tratar o prevenir alteraciones del sueno y enfermedades asociadas usando dosis muy bajas de ciclobenzaprina
NO20075344L (no) Metforminbaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse
Tuma et al. Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN
Woode et al. An evaluation of the anti-inflammatory, antipyretic and antinociceptive effects of Ficus exasperata (Vahl) leaf extract
Pletscher et al. Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzoquinolizine derivatives
Ainooson et al. Trichilia monadelpha bark extracts inhibit carrageenan-induced foot-oedema in the 7-day old chick and the oedema associated with adjuvant-induced arthritis in rats
Baranwal et al. Anti-arthritic activity of some indigenous plants: a review
Castelli et al. A Review of Pharmacology of NCS‐382, a Putative Antagonist of γ‐Hydroxybutyric Acid (GHB) Receptor
Ögren et al. Anti‐aggressive effect of zimelidine in isolated mice
Nwafor et al. Analgesic and anti-inflammatory activities of an ethanol extract of Smilax krausiana leaf in mice
Baggio et al. Role of brain dopaminergic mechanisms in rodent aggressive behavior: Influence of (±) Nn-propyl-norapomorphine on three experimental models
Abe et al. γ-Acid Metabolism in Subcellular Particles of Mouse Brain and Its Relationship to Convulsions
Otimenyin et al. Antiinflamatory and analgesic activities of Ficus thonningii and Pseudocedrela kotschyi extracts
PÄHKLA et al. Behavioural effects of pinoline in the rat forced swimming, open field and elevated plus-maze tests
Maleki Effect of ethanolic extract of Safflower on naloxone-induced morphine withdrawal signs in mice
JP2019517468A (ja) 付加的抗うつ剤組成物及びその使用方法
Kempf et al. Effect of valproic acid on brain serotonin metabolism in isolated and grouped rats
Lee et al. Effect of Mixture extracted from Bupleuri Radix and Physalidis Herba on the LPS-induced depression in Rats
Spinnewyn et al. An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats
RU2006134249A (ru) Способ прекращения курения
Levine et al. Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior
Ganu et al. Anticonvulsant activity of a Mimusops elengi in experimental animals